申请人:Novabiotics Limited
公开号:US20180344671A1
公开(公告)日:2018-12-06
The present invention relates to compositions of cysteamine or a derivative thereof for use in the treatment or prophylaxis or a disease or condition associated with neutrophil elastase activity. The compositions can be administered, e.g., by inhalation, intravenously, or topically, as appropriate.